Roshanak Tirdad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roshanak Tirdad has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Hamid Ghaderi
Department of Cardiovascular Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publications - Manouchehr Hekmat
Department of Cardiovascular Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publications - Seyedeh Adeleh Mirjafari
Department of Pediatrics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publications - Zahra Ansari Aval
Department of Cardiovascular Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publications - Mahya Hekmat
Shahid Beheshti University of Medical Sciences. Tehran, Iran
2 shared publications - Mandana Hekmat
Shahid Beheshti University of Medical Sciences. Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 30 December 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 14 (1) , e11664
Presentation of a case of chest pain leading to coronary artery bypass grafting (CABG) following the third dose of COVID-19 vaccination and an overview of the possible causes of chest pain after COVID-19 vaccination
In the wake of widespread COVID-19 vaccinations, a variety of complications have been reported. Among these, cardiac ischemia stands out as a rare, but significant and potentially dangerous complication, which can progress to myocardial infarction and pose a serious threat to one’s life. Our patient was a 54-year-old man with no risk factors, who developed chest pain five days after the third dose of the COVID-19 vaccine. Notably, he exhibited no symptoms after the first and second doses. For four months, the patient’s symptoms were attributed to inflammatory complications, such as pericarditis and myocarditis, as well as gastrointestinal problems. During this period, he received symptomatic treatment. Due to the persistence of symptoms, heart examinations were conducted, which revealed a constriction at the end of the left main coronary artery. Consequently, the patient underwent coronary artery bypass grafting (CABG). Following cardiac revascularization, the patient’s symptoms were successfully alleviated. Furthermore, his cardiac symptoms were successfully resolved during a six-month follow-up period. The mechanism through which asymptomatic plaques in the coronary vessels are activated following the COVID-19 vaccination or infection remains unclear. Regardless of the cause, any chest discomfort experienced after COVID-19 vaccination or infection should be treated with utmost seriousness, and examinations for acute coronary syndrome should be conducted.
- 30 December 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 14 (1) , e11664
Open AccessPresentation of a case of chest pain leading to coronary artery bypass grafting (CABG) following the third dose of COVID-19 vaccination and an overview of the possible causes of chest pain after COVID-19 vaccination
In the wake of widespread COVID-19 vaccinations, a variety of complications have been reported. Among these, cardiac ischemia stands out as a rare, but significant and potentially dangerous complication, which can progress to myocardial infarction and pose a serious threat to one’s life. Our patient was a 54-year-old man with no risk factors, who developed chest pain five days after the third dose of the COVID-19 vaccine. Notably, he exhibited no symptoms after the first and second doses. For four months, the patient’s symptoms were attributed to inflammatory complications, such as pericarditis and myocarditis, as well as gastrointestinal problems. During this period, he received symptomatic treatment. Due to the persistence of symptoms, heart examinations were conducted, which revealed a constriction at the end of the left main coronary artery. Consequently, the patient underwent coronary artery bypass grafting (CABG). Following cardiac revascularization, the patient’s symptoms were successfully alleviated. Furthermore, his cardiac symptoms were successfully resolved during a six-month follow-up period. The mechanism through which asymptomatic plaques in the coronary vessels are activated following the COVID-19 vaccination or infection remains unclear. Regardless of the cause, any chest discomfort experienced after COVID-19 vaccination or infection should be treated with utmost seriousness, and examinations for acute coronary syndrome should be conducted.
- Open Access
- 29 January 2024
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
A rare case of hydatid cyst in the chordae tendineae of papillary muscle of the right ventricle
Hydatid cyst inside the cardiac chambers, especially the right ventricle, is a rare manifestation of the Echinococcus granulosus infection. We present a rare case of a mobile hydatid cyst on the chordae tendineae of the right ventricular papillary muscle. An 11-year-old male patient presented with multiple cysts in the body (numerous ones in the lung and liver) who had undergone left lung lobectomy due to a hydatid cyst prone to rupture. In the subsequent echocardiography, a fully mobile cyst measuring 2×1.5 cm was noticed in the right ventricle. Although the child had no cardiac presentation, due to the risk posed by its location and the high probability of sudden death or embolism, he underwent a successful cardiac and pulmonary bypass operation, and the cyst was completely excised. It was located on the chordae tendineae of the papillary muscle. In agricultural and rural countries and regions, cardiac hydatid cysts should be considered at any age. Due to the high risk of complications and mortality in cardiac hydatid cysts, regardless of the symptoms, inpatients with a positive history, cardiac examination with echocardiography must be included in diagnostic protocols. These cysts should be surgically removed as soon as possible on diagnosis, regardless of the symptoms.
- 29 January 2024
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Open AccessA rare case of hydatid cyst in the chordae tendineae of papillary muscle of the right ventricle
Hydatid cyst inside the cardiac chambers, especially the right ventricle, is a rare manifestation of the Echinococcus granulosus infection. We present a rare case of a mobile hydatid cyst on the chordae tendineae of the right ventricular papillary muscle. An 11-year-old male patient presented with multiple cysts in the body (numerous ones in the lung and liver) who had undergone left lung lobectomy due to a hydatid cyst prone to rupture. In the subsequent echocardiography, a fully mobile cyst measuring 2×1.5 cm was noticed in the right ventricle. Although the child had no cardiac presentation, due to the risk posed by its location and the high probability of sudden death or embolism, he underwent a successful cardiac and pulmonary bypass operation, and the cyst was completely excised. It was located on the chordae tendineae of the papillary muscle. In agricultural and rural countries and regions, cardiac hydatid cysts should be considered at any age. Due to the high risk of complications and mortality in cardiac hydatid cysts, regardless of the symptoms, inpatients with a positive history, cardiac examination with echocardiography must be included in diagnostic protocols. These cysts should be surgically removed as soon as possible on diagnosis, regardless of the symptoms.
- Open Access
- 28 November 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (1) , e11649
Should a forgotten guidewire be removed after years? An undesirable complication of hemodialysis catheter wire left in the body
Today, one of the most common methods used in the emergency room or intensive care unit (ICU) in patients is the Seldinger technique to access the central venous system, shunting for hemodialysis, intra-aortic balloon pump, or arterial insertion. Accidental leaving of the guide wire is an uncommon but important complication that can occur as a result of an incorrect technique, and it is sometimes found accidentally or due to complications years after the procedure. The case is a 53-year-old patient who underwent aortic valve replacement with a mechanical valve and mitral valve repair with a ring 12 years ago and was treated with warfarin. Two years after the heart surgery, due to chronic renal failure, the patient underwent dialysis, and after the preparation of an arteriovenous fistula, he underwent stenting. After approximately ten years, the patient developed fever, chills, and shortness of breath. During the examination, endocarditis was diagnosed, and a part of the aortic valve was released. There was a severe paravalvular leak in the aortic valve, and an abscess was formed in the aorta root. We also noticed a forgotten guide wire in the superior vena cava, right atrium, inferior vena cava, and hepatic vein, and echogenic masses were located on the guidewire. The diagnosis was confirmed by echocardiography, chest x-ray, and phenocopy. After antibiotic therapy, the patients underwent heart surgery, aortic valve replacement, and aortic root repair, and the guidewire was removed (70 cm long). Unfortunately, despite all measures, the patient died a few days after the surgery. Due to complications, a forgotten guidewire should be removed immediately after diagnosis. The preferred intervention is the removal of the guidewire by endovascular interventions, but surgical treatment should also be considered in some cases.
- 28 November 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (1) , e11649
Open AccessShould a forgotten guidewire be removed after years? An undesirable complication of hemodialysis catheter wire left in the body
Today, one of the most common methods used in the emergency room or intensive care unit (ICU) in patients is the Seldinger technique to access the central venous system, shunting for hemodialysis, intra-aortic balloon pump, or arterial insertion. Accidental leaving of the guide wire is an uncommon but important complication that can occur as a result of an incorrect technique, and it is sometimes found accidentally or due to complications years after the procedure. The case is a 53-year-old patient who underwent aortic valve replacement with a mechanical valve and mitral valve repair with a ring 12 years ago and was treated with warfarin. Two years after the heart surgery, due to chronic renal failure, the patient underwent dialysis, and after the preparation of an arteriovenous fistula, he underwent stenting. After approximately ten years, the patient developed fever, chills, and shortness of breath. During the examination, endocarditis was diagnosed, and a part of the aortic valve was released. There was a severe paravalvular leak in the aortic valve, and an abscess was formed in the aorta root. We also noticed a forgotten guide wire in the superior vena cava, right atrium, inferior vena cava, and hepatic vein, and echogenic masses were located on the guidewire. The diagnosis was confirmed by echocardiography, chest x-ray, and phenocopy. After antibiotic therapy, the patients underwent heart surgery, aortic valve replacement, and aortic root repair, and the guidewire was removed (70 cm long). Unfortunately, despite all measures, the patient died a few days after the surgery. Due to complications, a forgotten guidewire should be removed immediately after diagnosis. The preferred intervention is the removal of the guidewire by endovascular interventions, but surgical treatment should also be considered in some cases.
- Open Access
- 29 July 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
Cardiac surgery of aortic valve and ascending aorta (Bentall procedure) in a patient with Fabry disease without enzyme replacement therapy: an overview of aortic and aortic valve surgical tips
Introduction: Fabry disease (FD) is a rare disease in which cardiovascular events are one of its manifestations. Aortic and mitral valve involvement are among its manifestations, but due to the concern of suture failure without enzyme replacement therapy (ERT), the desire for its surgery has been very low, and its reported cases have been few. After the introduction of ERT, cardiovascular surgery for such patients has been gradually reported from different places, but due to the high cost of ERT, it is not practically available to patients in the third world and the backward countries. Reports of the experiences of patients with FD who underwent cardiac surgery without ERT can help improve cardiac surgery in these patients. Case Report: A 34-year-old man diagnosed with FD due to chronic renal failure and underwent dialysis 3 times a week for 1.5 years became a candidate for kidney transplant. In pre-transplant examinations, dilatation of aortic root and aortic valve insufficiency were diagnosed, and the patient’s kidney transplant surgery was postponed until after cardiac surgery. The patient underwent cardiac surgery, aortic valve replacement, and ascending aortic replacement, as well as re-implantation of both right and left coronary buttons on the ascending aorta (Bentall procedure). The post-surgery period passed without any special event. The patient’s dialysis continued; after 4 months, he underwent kidney transplant surgery, and the one-year follow-up period also was good. Conclusion: Although there is very little evidence of cardiovascular surgery in patients with FD without ERT, and surgeons have always been worried about suture failure and complications of cardiac surgery, due to the high cost of ERT, this treatment is not available to everyone. The introduced patient underwent cardiac surgery by Bentall procedure without receiving ERT and was discharged without any special complications. By reporting and collecting similar cases, guidance may be provided for patients with FD for whom ERT is not available.
- 29 July 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
Open AccessCardiac surgery of aortic valve and ascending aorta (Bentall procedure) in a patient with Fabry disease without enzyme replacement therapy: an overview of aortic and aortic valve surgical tips
Introduction: Fabry disease (FD) is a rare disease in which cardiovascular events are one of its manifestations. Aortic and mitral valve involvement are among its manifestations, but due to the concern of suture failure without enzyme replacement therapy (ERT), the desire for its surgery has been very low, and its reported cases have been few. After the introduction of ERT, cardiovascular surgery for such patients has been gradually reported from different places, but due to the high cost of ERT, it is not practically available to patients in the third world and the backward countries. Reports of the experiences of patients with FD who underwent cardiac surgery without ERT can help improve cardiac surgery in these patients. Case Report: A 34-year-old man diagnosed with FD due to chronic renal failure and underwent dialysis 3 times a week for 1.5 years became a candidate for kidney transplant. In pre-transplant examinations, dilatation of aortic root and aortic valve insufficiency were diagnosed, and the patient’s kidney transplant surgery was postponed until after cardiac surgery. The patient underwent cardiac surgery, aortic valve replacement, and ascending aortic replacement, as well as re-implantation of both right and left coronary buttons on the ascending aorta (Bentall procedure). The post-surgery period passed without any special event. The patient’s dialysis continued; after 4 months, he underwent kidney transplant surgery, and the one-year follow-up period also was good. Conclusion: Although there is very little evidence of cardiovascular surgery in patients with FD without ERT, and surgeons have always been worried about suture failure and complications of cardiac surgery, due to the high cost of ERT, this treatment is not available to everyone. The introduced patient underwent cardiac surgery by Bentall procedure without receiving ERT and was discharged without any special complications. By reporting and collecting similar cases, guidance may be provided for patients with FD for whom ERT is not available.
- Open Access
- 20 June 2023
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Recurrent cardiac hydatid cysts with pericardial protrusion; a rare case presentation of Echinococcus granulosus
Hydatid cyst (HC) is a rare pathology mostly found in less developed, livestock-raising countries. HC can be found anywhere in the body, however it is a rare finding in the heart, and its recurrence in the heart and pericardium is very rare. A 54-year-old woman who had undergone surgery for the removal of HC in another country 11 years before presented with shortness of breath and heaviness in the chest. The examinations and computerized tomography (CT) scan revealed a large mass measuring 60×50 mm in the pericardium cavity originating from the right atrial wall. Infection with Echinococcus granulosus was confirmed with serological enzyme-linked immunosorbent assay (ELISA) test and the patient underwent cardiac surgery. The patient underwent cardiopulmonary bypass, nevertheless did not suffer cardiac arrest, and aortic cross-clamping was not performed for her. The removed mass was filled with daughter cysts. The endocysts were removed and intramural cysts were drained. Following the surgery, the patient received treatment with albendazole for six months. Cardiac hydatid cyst recurrence is a rare but possible incident, and annual follow-ups and echocardiography are recommended.
- 20 June 2023
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Open AccessRecurrent cardiac hydatid cysts with pericardial protrusion; a rare case presentation of Echinococcus granulosus
Hydatid cyst (HC) is a rare pathology mostly found in less developed, livestock-raising countries. HC can be found anywhere in the body, however it is a rare finding in the heart, and its recurrence in the heart and pericardium is very rare. A 54-year-old woman who had undergone surgery for the removal of HC in another country 11 years before presented with shortness of breath and heaviness in the chest. The examinations and computerized tomography (CT) scan revealed a large mass measuring 60×50 mm in the pericardium cavity originating from the right atrial wall. Infection with Echinococcus granulosus was confirmed with serological enzyme-linked immunosorbent assay (ELISA) test and the patient underwent cardiac surgery. The patient underwent cardiopulmonary bypass, nevertheless did not suffer cardiac arrest, and aortic cross-clamping was not performed for her. The removed mass was filled with daughter cysts. The endocysts were removed and intramural cysts were drained. Following the surgery, the patient received treatment with albendazole for six months. Cardiac hydatid cyst recurrence is a rare but possible incident, and annual follow-ups and echocardiography are recommended.
- Open Access
- 19 December 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e20062
Do antibacterial or antiviral filters protect operating room staff by preventing COVID-19 virus spread from cardiopulmonary bypass machine during open hear surgeries? A case report
Open heart surgeries are inevitable during pandemic and there is the possibility of corona virus transmission through oxygenated exhaust during cardiopulmonary bypass (CBP). In this study, researchers try to test the hypothesis by placing an antiviral and antibacterial filter in the air outlet of the oxygenator in order to prevent spread of COVID-19 virus in operating room. The COVID-19 positive patient needed emergency open-heart surgery due to her critical situation. The patient was under cardiopulmonary bypass for almost two hours. Antibacterial and antiviral filters were placed in oxygenator outlet. At the end of the procedure, polymerase chain reaction (PCR) swab was taken from both sides of the filter. The result of the test behind the filter was positive, but at the other side of the filter was negative. This may suggest, the exhaust air from the oxygenator can spread viruses into the room and the antibacterial and antiviral filters may be able to prevent operating room contamination. The installation of filter in the oxygenator exhaust can prevent the spread of COVID-19 viruses into the operating room air. Using this cheap and affordable method, operating room staff safety can be assured.
- 19 December 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e20062
Open AccessDo antibacterial or antiviral filters protect operating room staff by preventing COVID-19 virus spread from cardiopulmonary bypass machine during open hear surgeries? A case report
Open heart surgeries are inevitable during pandemic and there is the possibility of corona virus transmission through oxygenated exhaust during cardiopulmonary bypass (CBP). In this study, researchers try to test the hypothesis by placing an antiviral and antibacterial filter in the air outlet of the oxygenator in order to prevent spread of COVID-19 virus in operating room. The COVID-19 positive patient needed emergency open-heart surgery due to her critical situation. The patient was under cardiopulmonary bypass for almost two hours. Antibacterial and antiviral filters were placed in oxygenator outlet. At the end of the procedure, polymerase chain reaction (PCR) swab was taken from both sides of the filter. The result of the test behind the filter was positive, but at the other side of the filter was negative. This may suggest, the exhaust air from the oxygenator can spread viruses into the room and the antibacterial and antiviral filters may be able to prevent operating room contamination. The installation of filter in the oxygenator exhaust can prevent the spread of COVID-19 viruses into the operating room air. Using this cheap and affordable method, operating room staff safety can be assured.
- Open Access
- 1 January 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 8 (1) , e24065
Introducing a very rare case of intra-pericardial thyroid tissue with blood supply from the aortic arch in a patient with renal cell carcinoma: A case report and review of the literature
Intra-pericardial heterotopic thyroid (IPHT) is an incidental finding during open-heart surgery. Although heterotopic thyroid has been reported in different parts of the body, only a few cases of intra-pericardium have been reported so far. In most articles, intracardiac, intrathoracic and heterotopic thymus cases are mistakenly included as IPTH cases A 57-year-old man with a history of non-Hodgkin lymphoma, who was treated 8 years ago and recovered, is now a candidate for surgery due to clear cell renal carcinoma in the left kidney with inferior vena cava (IVC) thrombus tumor that has spread into the right atrium. At the same time, he was operated on by two teams of urology and heart surgery. The patient’s kidney was removed, and then he was subjected to sternotomy by the heart surgery team to remove the thrombus tumor. After opening the pericardium inside the pericardial cavity, a pericardial mass measuring 1×2 ×3 cm, which was connected to the lower surface of the aortic arch by a 1 cm long stalk, was observed. It was resected and sent to pathology laboratory. The rest of the surgery to remove the thrombus tumor from inside the right atrium and IVC continued according to the procedure. The pathological report was benign thyroid tissue. Actual cases of IPTH are underreported, and due to the small number, it is not yet possible to comment on the prevalence of malignancy in it or its functional role; However any lesion or abnormal mass in the pericardial cavity should be respected and sent to pathology laboratory therefore by collecting information about these masses, in the future, decisions can be made and summarized.
- 1 January 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 8 (1) , e24065
Open AccessIntroducing a very rare case of intra-pericardial thyroid tissue with blood supply from the aortic arch in a patient with renal cell carcinoma: A case report and review of the literature
Intra-pericardial heterotopic thyroid (IPHT) is an incidental finding during open-heart surgery. Although heterotopic thyroid has been reported in different parts of the body, only a few cases of intra-pericardium have been reported so far. In most articles, intracardiac, intrathoracic and heterotopic thymus cases are mistakenly included as IPTH cases A 57-year-old man with a history of non-Hodgkin lymphoma, who was treated 8 years ago and recovered, is now a candidate for surgery due to clear cell renal carcinoma in the left kidney with inferior vena cava (IVC) thrombus tumor that has spread into the right atrium. At the same time, he was operated on by two teams of urology and heart surgery. The patient’s kidney was removed, and then he was subjected to sternotomy by the heart surgery team to remove the thrombus tumor. After opening the pericardium inside the pericardial cavity, a pericardial mass measuring 1×2 ×3 cm, which was connected to the lower surface of the aortic arch by a 1 cm long stalk, was observed. It was resected and sent to pathology laboratory. The rest of the surgery to remove the thrombus tumor from inside the right atrium and IVC continued according to the procedure. The pathological report was benign thyroid tissue. Actual cases of IPTH are underreported, and due to the small number, it is not yet possible to comment on the prevalence of malignancy in it or its functional role; However any lesion or abnormal mass in the pericardial cavity should be respected and sent to pathology laboratory therefore by collecting information about these masses, in the future, decisions can be made and summarized.